273 related articles for article (PubMed ID: 7977848)
1. Prolonged stimulation of intrarenal V1 vasopressin receptors results in sustained hypertension.
Szczepanska-Sadowska E; Stepniakowski K; Skelton MM; Cowley AW
Am J Physiol; 1994 Nov; 267(5 Pt 2):R1217-25. PubMed ID: 7977848
[TBL] [Abstract][Full Text] [Related]
2. In vivo diuretic actions of renal vasopressin V1 receptor stimulation in rats.
Ledderhos C; Mattson DL; Skelton MM; Cowley AW
Am J Physiol; 1995 Mar; 268(3 Pt 2):R796-807. PubMed ID: 7900923
[TBL] [Abstract][Full Text] [Related]
3. Chronic intravenous administration of V1 arginine vasopressin agonist results in sustained hypertension.
Cowley AW; Szczepanska-Sadowska E; Stepniakowski K; Mattson D
Am J Physiol; 1994 Aug; 267(2 Pt 2):H751-6. PubMed ID: 8067431
[TBL] [Abstract][Full Text] [Related]
4. Effects of long-term vasopressin receptor stimulation on medullary blood flow and arterial pressure.
Cowley AW; Skelton MM; Kurth TM
Am J Physiol; 1998 Nov; 275(5):R1420-4. PubMed ID: 9791056
[TBL] [Abstract][Full Text] [Related]
5. Control of renal medullary blood flow by vasopressin V1 and V2 receptors.
Nakanishi K; Mattson DL; Gross V; Roman RJ; Cowley AW
Am J Physiol; 1995 Jul; 269(1 Pt 2):R193-200. PubMed ID: 7631893
[TBL] [Abstract][Full Text] [Related]
6. Effects of the vasopressin V1 agonist [Phe2,Ile3,Orn8]] vasopressin on regional kidney perfusion and renal excretory function in anesthetized rabbits.
Evans RG; Bergström G; Lawrence AJ
J Cardiovasc Pharmacol; 1998 Oct; 32(4):571-81. PubMed ID: 9781925
[TBL] [Abstract][Full Text] [Related]
7. Effects of renal medullary infusion of a vasopressin V1 agonist on renal antihypertensive mechanisms in rabbits.
Bergström G; Evans RG
Am J Physiol; 1998 Jul; 275(1):R76-85. PubMed ID: 9688963
[TBL] [Abstract][Full Text] [Related]
8. Role of V1 receptors in the action of vasopressin on the baroreflex control of heart rate.
Luk J; Ajaelo I; Wong V; Wong J; Chang D; Chou L; Reid IA
Am J Physiol; 1993 Sep; 265(3 Pt 2):R524-9. PubMed ID: 8214142
[TBL] [Abstract][Full Text] [Related]
9. The effect of AVP-V receptor stimulation on local GFR in the rat kidney.
Roald AB; Tenstad O; Aukland K
Acta Physiol Scand; 2004 Oct; 182(2):197-204. PubMed ID: 15450116
[TBL] [Abstract][Full Text] [Related]
10. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors.
Feng JJ; Arendshorst WJ
Am J Physiol; 1996 Aug; 271(2 Pt 2):F304-13. PubMed ID: 8770161
[TBL] [Abstract][Full Text] [Related]
11. V2-like vasopressin receptor mobilizes intracellular Ca2+ in rat medullary collecting tubules.
Champigneulle A; Siga E; Vassent G; Imbert-Teboul M
Am J Physiol; 1993 Jul; 265(1 Pt 2):F35-45. PubMed ID: 8342613
[TBL] [Abstract][Full Text] [Related]
12. Arginine vasopressin increases renal sodium excretion in the anesthetized rat through V1 receptors.
Musabayane CT; Forsling ML; Balment RJ
Ren Fail; 1997 Jan; 19(1):23-32. PubMed ID: 9044449
[TBL] [Abstract][Full Text] [Related]
13. V1- and V2-receptor contributions to ovine fetal renal and cardiovascular responses to vasopressin.
Ervin MG; Ross MG; Leake RD; Fisher DA
Am J Physiol; 1992 Apr; 262(4 Pt 2):R636-43. PubMed ID: 1566929
[TBL] [Abstract][Full Text] [Related]
14. Baroreflex buffering of pressor response to vasopressin is mediated by V1, not V2, receptors in conscious rats.
Shimizu K; Schwartz J; McGrath BP
Am J Physiol; 1993 Feb; 264(2 Pt 2):R345-9. PubMed ID: 8447490
[TBL] [Abstract][Full Text] [Related]
15. Central cardiovascular effects of AVP and AVP analogs with V1, V2 and 'V3' agonistic or antagonistic properties in conscious dog.
Noszczyk B; Lon S; Szczepańska-Sadowska E
Brain Res; 1993 Apr; 610(1):115-26. PubMed ID: 8518919
[TBL] [Abstract][Full Text] [Related]
16. Increased pressor function of central vasopressinergic system in hypertensive renin transgenic rats.
Szczepańska-Sadowska E; Paczwa P; Loń S; Ganten D
J Hypertens; 1998 Oct; 16(10):1505-14. PubMed ID: 9814623
[TBL] [Abstract][Full Text] [Related]
17. Effects of vasopressin and V1 receptors blockade on blood pressure and heart rate in spontaneously hypertensive rats.
Stepniakowski K; Lapiński M; Noszczyk B; Januszewicz A; Szczepańska-Sadowska E
Pol J Pharmacol Pharm; 1991; 43(6):487-93. PubMed ID: 1840331
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of V2 vasopressin agonist and antagonists on blood pressure regulation in normotensive (WKY) and spontaneously hypertensive (SHR) rats.
Budzikowski A; Lon S; Paczwa P; Szczepanska-Sadowska E
J Auton Nerv Syst; 1992 Jun; 39(2):87-95. PubMed ID: 1430797
[TBL] [Abstract][Full Text] [Related]
19. Role of vasopressin in renal vascular changes with hypoxemia and hypercapnic acidosis in conscious dogs.
Rose CE; Ragsdale NV; Carey RM
Am J Physiol; 1990 Oct; 259(4 Pt 2):R690-702. PubMed ID: 2145777
[TBL] [Abstract][Full Text] [Related]
20. Arginine vasopressin-mediated stimulation of nitric oxide within the rat renal medulla.
Park F; Zou AP; Cowley AW
Hypertension; 1998 Nov; 32(5):896-901. PubMed ID: 9822450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
